FOXD2 inhibitors refer to a class of chemical compounds designed to modulate the activity of the FOXD2 protein, a transcription factor belonging to the forkhead box (FOX) family. These proteins are characterized by their distinctive forkhead or "winged-helix" DNA-binding domain, which allows them to regulate the expression of genes involved in various cellular processes. FOXD2, like other members of the FOX family, plays a crucial role in cell development, differentiation, and survival. Inhibitors of FOXD2 specifically interact with this transcription factor, reducing its ability to bind to target DNA sequences, which in turn can influence downstream signaling pathways and cellular responses. These inhibitors may act by directly interfering with the protein-DNA interaction or by modulating protein-protein interactions required for the proper functioning of FOXD2.
Structurally, FOXD2 inhibitors often include molecular features that enable them to engage the forkhead domain, thus disrupting its binding affinity for specific gene promoters. The specificity of these inhibitors is essential, as the FOX protein family is large, and off-target effects on other FOX proteins could result in unintended cellular consequences. The design of these inhibitors typically focuses on achieving high affinity for FOXD2 while maintaining selectivity to avoid cross-reactivity with related transcription factors. Chemical variations among FOXD2 inhibitors may include differences in hydrophobic or hydrophilic regions, which affect their bioavailability, cellular uptake, and interaction strength with the target protein. These structural features, combined with the complexity of FOXD2's role in gene regulation, make the development of FOXD2 inhibitors a sophisticated area of molecular design.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could inhibit FOXD2 expression by demethylating DNA at promoter regions specific to the FOXD2 gene, thereby silencing its transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an inhibitor of histone deacetylases, Trichostatin A may lead to a relaxed chromatin structure around the FOXD2 gene, resulting in decreased transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might repress FOXD2 expression through retinoic acid receptor-mediated repression of forkhead transcription factor genes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin can lead to a reduction in FOXD2 levels by inhibiting mTOR signaling, which is crucial for protein synthesis, including that of various transcription factors. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibition of the PI3K pathway by LY 294002 can lead to reduced activation of AKT, ultimately decreasing the transcriptional activity necessary for FOXD2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may lower FOXD2 expression by inhibiting MEK, which is part of the MAPK/ERK pathway that drives the transcription of many growth-related genes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 could inhibit JNK, leading to decreased activity of transcription factors that control FOXD2 gene expression, thereby reducing its levels. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, SB 203580 may lead to decreased FOXD2 expression by altering the phosphorylation state of transcription factors that control FOXD2 gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may downregulate FOXD2 expression by inhibiting NF-κB signaling, which is sometimes involved in the transcriptional activation of FOXD2. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might decrease FOXD2 expression through activation of SIRT1, leading to deacetylation of transcription factors and repressors that govern FOXD2 expression. | ||||||